CS logo
small CS logo
Centrum Medyczne Medyk

Rzeszow, Poland
Publiczne centrum medyczne w Rzeszowie

About Centrum Medyczne Medyk


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Boehringer Ingelheim
5
Janssen Research & Development, LLC
5
Celgene
4
Pfizer
3
Applied Molecular Transport
2
Arena Pharmaceuticals
2
Arrowhead Pharmaceuticals
2
Eli Lilly and Company
2
Amicus Therapeutics
1
AnaptysBio, Inc.
1
Total Rows: 27

Clinical Trials at Centrum Medyczne Medyk


During the past decade, Centrum Medyczne Medyk conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 21 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 13 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years77446633776677550000002266443355Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
2014-06-16
2016-05-12
Completed
521
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-11-14
2020-05-25
Completed
358
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
2015-06-30
2017-10-23
Completed
730

Rows per page:

1–50 of 50

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centrum Medyczne Medyk" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 27 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Medyk" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Dr. Falk Pharma GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 7Hoffmann-La Roche: 7Boehringer Ingelheim: 5Boehringer Ingelheim: 5Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5Celgene: 4Celgene: 4Pfizer: 3Pfizer: 3Applied Molecular Transport: 2Applied Molecular Transport: 2Arena Pharmaceuticals: 2Arena Pharmaceuticals: 2Arrowhead Pharmaceuticals: 2Arrowhead Pharmaceuticals: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Amicus Therapeutics: 1Amicus Therapeutics: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 5Eli Lilly and Company: 5Arena is a whollyowned subsidiary ofPfizer: 2Arena is a whollyowned subsidiary ofPfizer: 2ARMO BioSciences: 1ARMO BioSciences: 1Brigham and Women'sHospital: 1Brigham and Women'sHospital: 1Dr. Falk Pharma GmbH: 1Dr. Falk Pharma GmbH: 1Merck KGaA,Darmstadt, Germany: 1Merck KGaA,Darmstadt, Germany: 1Molecular Partners AG: 1Molecular Partners AG: 1Quintiles, Inc.: 1Quintiles, Inc.: 1Shire: 1Shire: 1

Clinical Trials Conditions at Centrum Medyczne Medyk


According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Medyk" are "Ulcerative Colitis" (9 trials), "Crohn Disease" (5 trials), "Crohn's Disease" (4 trials), "Colitis, Ulcerative" (3 trials) and "Multiple Sclerosis" (3 trials). Many other conditions were trialed in "Centrum Medyczne Medyk" in a lesser frequency.

Clinical Trials Intervention Types at Centrum Medyczne Medyk


Most popular intervention types in "Centrum Medyczne Medyk" are "Drug" (46 trials), "Biological" (8 trials), "Other" (6 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (27 trials), "Etrasimod" (4 trials), "Etrolizumab" (4 trials), "Guselkumab" (4 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Centrum Medyczne Medyk


The vast majority of trials in "Centrum Medyczne Medyk" are 50 trials for "All" genders.

Clinical Trials Status at Centrum Medyczne Medyk


Currently, there are NaN active trials in "Centrum Medyczne Medyk". undefined are not yet recruiting, 12 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Centrum Medyczne Medyk, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Medyczne Medyk, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 34Phase 3: 34Phase 2: 14Phase 2: 14Not Applicable: 2Not Applicable: 2Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 19Completed: 19Recruiting: 12Recruiting: 12Active, not recruiting: 11Active, not recruiting: 11Terminated: 7Terminated: 7Unknown status: 1Unknown status: 1